← Back to catalogue

17OHP AccuLite CLIA Test System - 192 Wells

FDA UDI

Class I (US FDA UDI)

by Monobind, Inc.

Identity

Trade Name
17OHP AccuLite CLIA Test System - 192 Wells FDA UDI
Generic Name
17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay FDA UDI
Model / Reference
5275-300 FDA UDI

Identifiers

Catalog Number
5275-300B FDA UDI
Primary DI / UDI-DI
00816870022888 FDA UDI
FDA Product Code
JLX FDA UDI
GMDN Term
17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1395 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dimensions & Sizes

Size
Width — 7.75 Inch FDA UDI

Category: 17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay

17OHP AccuLite CLIA Test System - 192 Wells by Monobind, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as 17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Monobind, Inc.

Sources (1)

  • FDA UDI db72656d-9eba-4be1-bd02-309beb24dd03 36 fields · synced May 29, 2026